Systematic review / meta-analysis / 2020
Red yeast rice extract was associated with reduced cardiovascular events and improved lipid profiles in MI patients with borderline hypercholesterolemia.
A meta-analysis of seven randomized controlled trials evaluated the efficacy of red yeast rice (RYR) extract in 10,699 myocardial infarction patients with borderline hypercholesterolemia. RYR extract (1,200 mg/day) reduced nonfatal MI (RR = 0.42, 95% CI 0.34 to 0.52), revascularization (RR = 0.58, 95% CI 0.48 to 0.71), and sudden death (RR = 0.71, 95% CI 0.53 to 0.94). It also lowered LDL (WMD = -20.70 mg/dL), TC (WMD = -26.61 mg/dL), and TG (WMD = -24.69 mg/dL), while increasing HDL levels (WMD = 2.71 mg/dL). Study follow-ups ranged from 4 weeks to 4.5 years, and studies were assessed as overall high quality with low risk of bias.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 10,699 myocardial infarction patients with borderline hypercholesterolemia across 7 studies
- What was measured
- Nonfatal MI, revascularization, sudden death, and lipid profiles (LDL, TC, TG, HDL)
THE PAPER
Efficacy of red yeast rice extract on myocardial infarction patients with borderline hypercholesterolemia: A meta-analysis of randomized controlled trials.
Sungthong B, Yoothaekool C, Promphamorn S, Phimarn W. Sci Rep, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.